EDUCATION CENTER

Does NAD+ therapy help with aging?

NAD+ (nicotinamide adenine dinucleotide) is essential for cellular energy metabolism and participates in pathways studied in aging biology. Levels can decline with age and metabolic stress. That biology is why clinics discuss NAD+ support—not because infusions or precursors have been proven to reverse human aging.

Some people report improved energy or recovery with clinician-directed NAD+ protocols; evidence quality varies by delivery method and outcome measured. NAD+ therapy should be framed as an adjunct under medical supervision, not a substitute for sleep, strength training, cardiometabolic risk control, or indicated hormone or metabolic care.

A Vita Bella provider can review whether NAD+ belongs in your plan after history, goals, and—when indicated—labs, rather than treating it as a longevity shortcut.

What is NAD+?

NAD+ is a coenzyme present in cells that helps convert nutrients into usable energy and supports enzymes involved in DNA repair and stress responses in research literature.

Oral precursors (such as NMN or NR in consumer markets), IV NAD+, and other routes are discussed differently and are not interchangeable. Product quality and dosing claims outside regulated channels vary widely.

How is NAD+ connected to aging?

Experimental and translational research links NAD+ metabolism to mitochondrial function and cellular maintenance pathways that change with age. That is a mechanistic story—not proof that raising NAD+ in clinic practice adds years of healthy life.

Fatigue, brain fog, and slower recovery have many causes (sleep apnea, iron deficiency, depression, thyroid disease, deconditioning, medications). Low energy alone does not prove an NAD+ deficit.

What does the research say?

NAD+ biology is an active research field. Human clinical evidence for anti-aging outcomes is still limited compared with foundational interventions such as blood-pressure control, not smoking, physical activity, and sleep.

When clinicians discuss NAD+, they usually target symptom or recovery goals with informed consent about uncertainty—not guaranteed epigenetic “age reversal.”

Be skeptical of marketing that cites animal data or single biomarkers as proof you will live longer.

Who may benefit from discussing NAD+?

Adults exploring clinician-guided wellness or recovery plans sometimes discuss NAD+ after basics are addressed. It is not first-line therapy for obesity, hypogonadism, or menopause symptoms.

Share full medication lists and medical history. People with complex illness need individualized risk review before IV or high-dose protocols.

What are the limits and risks?

IV infusions can cause flushing, nausea, or discomfort for some people. Product purity matters. Unsupervised high-dose use is not appropriate.

NAD+ does not replace GLP-1 therapy, TRT/HRT when indicated, or cancer screening. Stacking longevity products without a plan increases cost and confusion more often than benefit.

What should come before NAD+ in a longevity plan?

Prioritize strength training, protein-forward nutrition, sleep and apnea care, blood pressure, lipids, glucose, alcohol moderation, and age-appropriate screening.

Then decide whether NAD+ or other adjuncts add value. Foundations move population risk; boutique infusions do not replace them.

FAQs

References

1. 1. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22:119-141.

2. 2. National Institute on Aging. Healthy Aging Tips.

3. 3. U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition.

Related guides